EyePoint Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell EYPT and other ETFs, options, and stocks.About EYPT
EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands.
CEOJay S. Duker
CEOJay S. Duker
Employees165
Employees165
HeadquartersWatertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded1987
Founded1987
Employees165
Employees165
EYPT Key Statistics
Market cap1.46B
Market cap1.46B
Price-Earnings ratio-5.59
Price-Earnings ratio-5.59
Dividend yield—
Dividend yield—
Average volume947.28K
Average volume947.28K
High today$17.66
High today$17.66
Low today$16.59
Low today$16.59
Open price$16.80
Open price$16.80
Volume638.36K
Volume638.36K
52 Week high$17.66
52 Week high$17.66
52 Week low$3.91
52 Week low$3.91
Stock Snapshot
With a market cap of 1.46B, EyePoint Pharmaceuticals(EYPT) trades at $17.59. The stock has a price-to-earnings ratio of -5.59.
On 2025-12-05, EyePoint Pharmaceuticals(EYPT) stock traded between a low of $16.59 and a high of $17.66. Shares are currently priced at $17.59, which is +6.0% above the low and -0.4% below the high.
The EyePoint Pharmaceuticals(EYPT)'s current trading volume is 638.36K, compared to an average daily volume of 947.28K.
During the past year, EyePoint Pharmaceuticals(EYPT) stock moved between $3.91 at its lowest and $17.66 at its peak.
During the past year, EyePoint Pharmaceuticals(EYPT) stock moved between $3.91 at its lowest and $17.66 at its peak.
Analyst ratings
100%
of 12 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own EYPT. This list is generated using Robinhood data, and it’s not a recommendation.